Joint statement The proposed trade secrets directive could obstruct recent EU developments on transparency and endangers freedom of information and...
Activities
November 30, 2014
Campaigns
The analysis of the most worrying proposals of the pharmaceutical industry's wish list for the EU-US trade agreement reveals a...
November 14, 2014
Campaigns
The International Society of Drug Bulletins (ISDB), Medicines in Europe Forum (MiEF), Health Action International (HAI) Europe, Nordic Cochrane Centre...
October 16, 2014
Campaigns
On 2 October 2014, the European Medicines Agency (EMA) finally adopted its policy on access to clinical data. From 1...
September 23, 2014
Campaigns
Joint briefing paper by 7 organisations. The major advance in transparency brought by the adoption of the EU regulation on...
September 19, 2014
Campaigns
Joint response by HAI, ISDB and MiEF to a WHO public consultation. The WHO proposal to assign a "biological qualifier"...
September 16, 2014
Campaigns
Joint open letter to President Juncker by 28 organisations. Promoting profit over public health puts European citizens at risk. No...
September 15, 2014
Campaigns
Joint response to the EMA consultation by the Cochrane AEMG, HAI Europe, ISDB and MiEF. “Protection of personal data” must...
April 04, 2014
Campaigns
In their Joint Response to a consultation by the US Institute of Medicine (IOM), HAI Europe, ISDB, MiEF and TACD...
March 24, 2014
Campaigns
A report by the civil society partners shows that the pharmaceutical industry's wish list for the Transatlantic Trade and Investment...